UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 19, 2017 5:00 P.M.
Form:
F-1
CIK:
0001444192
Company Name:
Acasti Pharma Inc.
File Number:
333-220755